Table: Rohto -Q1 group results

Rohto Pharmaceutical

08/08/2017 07:00

Aug 8 (Reuters)-  
             Rohto Pharmaceutical Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                   3 months ended      3 months ended       Year to  
                  Jun 30, 2017        Jun 30, 2016     Mar 31, 2018  
                     LATEST             YEAR-AGO          LATEST     
                     RESULTS             RESULTS         FORECAST    
  Sales               35.84               32.88           158.50     
                   (+9.0 pct)          (-7.2 pct)       (+2.5 pct)   
  Operating            3.43                2.22            15.60     
                   (+54.9 pct)         (+19.4 pct)      (+1.0 pct)   
  Recurring            3.60                2.43            16.00     
                   (+48.0 pct)         (+13.1 pct)      (+0.2 pct)   
  Net                  2.28                1.37            10.20     
                   (+65.7 pct)         (+3.4 pct)       (+1.9 pct)   
  EPS               19.98 yen           12.07 yen        89.54 yen   
  EPS Diluted       19.89 yen           12.02 yen                    
  Ann Div                               21.00 yen        22.00 yen   
  -Q2 div                               10.00 yen        11.00 yen   
  -Q4 div                               11.00 yen        11.00 yen   
   
  NOTE - Rohto Pharmaceutical Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T  
  ((Tokyo Headline News Desk +813 6441 1812))